The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
Open accessAbstract
OBJECTIVES: To provide updated estimates of Alzheimer disease (AD) dementia prevalence in the United States from 2010 through 2050. METHODS: Probabilities of AD dementia incidence were calculated from a longitudinal, population-based study including substantial numbers of both black and white participants. Incidence probabilities for single year of age, race, and level of education were calculated using weighted logistic regression and AD dementia diagnosis from 2,577 detailed clinical evaluations of 1,913 people obtained from stratified random samples of previously disease-free individuals in a population of 10,800. These were combined with US mortality, education, and new US Census Bureau estimates of current and future population to estimate current and future numbers of people with AD dementia in the United States. RESULTS: We estimated that in 2010, there were 4.7 million individuals aged 65 years or older with AD dementia (95% confidence interval [CI] = 4.0-5.5). Of these, 0.7 million (95% CI = 0.4-0.9) were between 65 and 74 years, 2.3 million were between 75 and 84 years (95% CI = 1.7-2.9), and 1.8 million were 85 years or older (95% CI = 1.4-2.2). The total number of people with AD dementia in 2050 is projected to be 13.8 million, with 7.0 million aged 85 years or older. CONCLUSION: The number of people in the United States with AD dementia will increase dramatically in the next 40 years unless preventive measures are developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As the U.S. population ages, the number of people with Alzheimer’s disease and related dementias (ADRD) is rapidly increasing,1,2”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sex is an important factor that contributes to the clinical and biological heterogeneities in Alzheimer’s disease (AD)”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The aging of the baby-boom generation will significantly increase the number of people in the United States with Alzheimer's.70”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“The aging of the population, including the baby‐boom generation, will significantly increase the number of people in the United States with Alzheimer's dementia.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [78]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Of all AD patients in the United States, around two-thirds are women [2].”
From Sex specific molecular networks and key drivers of Alzheimer’s disease (2023) · cites this paper as [2]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Almost two-thirds of AD patients in the U.S. are women [2]”
From Sex-specific DNA methylation differences in Alzheimer’s disease pathology (2021) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,385
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Self-citationPrevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932
Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,802
2005 American Community Survey 1-Year Estimates
(2016) · Cited by 1,241
Missed and Delayed Diagnosis of Dementia in Primary Care: Prevalence and Contributing Factors
Bradford, A., Kunik, M. E., Schulz, P., Williams, S. P., & Singh, H. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181a6bebc · Cited by 969
Glover, J. W. (2010) · Cited by 917
Age-specific incidence rates of Alzheimer’s disease: The Baltimore Longitudinal Study of Aging
Kawas, C., Gray, S., Brookmeyer, R., Fozard, J., & Zonderman, A. (2000) · Neurology · doi:10.1212/wnl.54.11.2072 · Cited by 472
Research works printed but not linked: 1
- Bienias JL Kott PS Evans DA. Applying the delete-a-group jacknife varience estimator to analyses of data from a complex longitudinal survey . Proceedings of the Annual Meeting of the American Statistical Association Section on Survey Research Methods. Alexandria: American Statistical Association; 2003:539–544.
Cited by
Sorted by citations
Items 201–300 of 1,012
Akyol, S., Ugur, Z., Yılmaz, A., Ustun, I., Gorti, S. K. K., Oh, K., McGuinness, B., Passmore, P., Kehoe, P. G., Maddens, M. E., et al. (2021) · Cells · doi:10.3390/cells10102591 · Cited by 138
Autophagy Dysfunction in Alzheimer’s Disease: Mechanistic Insights and New Therapeutic Opportunities
Di Meco, A., Curtis, M. E., Lauretti, E., & Praticò, D. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.05.008 · Cited by 133
Hazzan, A. A., Dauenhauer, J. A., Follansbee, P., Hazzan, J. O., Allen, K., & Omobepade, I. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-02787-0 · Cited by 133
Animal models of Alzheimer disease: historical pitfalls and a path forward
Cavanaugh, S. E. (2014) · ALTEX · doi:10.14573/altex.1310071 · Cited by 132
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
Aso, E., & Ferrer, I. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00243 · Cited by 131
Harrison, J. K., Fearon, P. A., Noel-Storr, A. H., McShane, R. H., Stott, D. J., & Quinn, T. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010772.pub2 · Cited by 135
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Association of Midlife Hearing Impairment With Late-Life Temporal Lobe Volume Loss
Armstrong, N. M., An, Y., Doshi, J. J., Erus, G., Ferrucci, L., Davatzikos, C. A., Deal, J. A., Lin, F. R., & Resnick, S. M. (2019) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2019.1610 · Cited by 135
Public knowledge and beliefs about dementia risk reduction: a national survey of Australians
Smith, B. J., Ali, S., & Quach, H. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-661 · Cited by 129
The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer’s Disease
Deardorff, W. J., Feen, E. S., & Grossberg, G. T. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0273-x · Cited by 136
Dassel, K. B., Carr, D. C., & Vitaliano, P. (2017) · The Gerontologist · doi:10.1093/geront/gnv148 · Cited by 127
Occupational cognitive requirements and late-life cognitive aging
Pool, L. R., Weuve, J., Wilson, R. S., Bültmann, U., Evans, D. A., & Mendes de Leon, C. F. (2016) · Neurology · doi:10.1212/wnl.0000000000002569 · Cited by 128
Self-citationKamal, M. S., Northcote, A., Chowdhury, L., Dey, N., Crespo, R. A. G., & Herrera‐Viedma, E. (2021) · IEEE Transactions on Instrumentation and Measurement · doi:10.1109/tim.2021.3107056 · Cited by 131
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
Mungenast, A. E., Siegert, S., & Tsai, L. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.010 · Cited by 136
García, M. A., Downer, B. G., Chiu, C., Saenz, J. L., Rote, S. M., & Wong, R. (2017) · The Gerontologist · doi:10.1093/geront/gnx142 · Cited by 127
Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?
Doulberis, M., Kotronis, G., Thomann, R., Pοlyzos, S. A., Boziki, M. K., Gialamprinou, D., Deretzi, G., Katsinelos, P., & Kountouras, J. (2017) · Helicobacter · doi:10.1111/hel.12454 · Cited by 134
Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease
Huang, Z., Wong, L., Su, Y., Huang, X., Wang, N., Chen, H., & Yi, C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100857 · Cited by 135
Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
Barini, E., Antico, O., Zhao, Y., Asta, F., Tucci, V., Catelani, T., Marotta, R., Xu, H., & Gasparini, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0082-7 · Cited by 126
Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease
Escott-Price, V., Shoai, M., Pither, R., Williams, J., & Hardy, J. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.018 · Cited by 183
Alasmari, F., Alshammari, M. A., Alasmari, A. F., Alanazi, W. A., & Alhazzani, K. (2018) · BioMed Research International · doi:10.1155/2018/3087475 · Cited by 125
Modeling Neurodegenerative Disorders in Drosophila melanogaster
Bolus, H., Crocker, K. L., Boekhoff‐Falk, G., & Chtarbanova, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093055 · Cited by 137
Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US
Maust, D. T., Strominger, J., Kim, H. M., Langa, K. M., Bynum, J., Chang, C., Kales, H. C., Zivin, K., Solway, E. S., & Marcus, S. C. (2021) · JAMA · doi:10.1001/jama.2021.1195 · Cited by 132
Evaluation of Ocular Perfusion in Alzheimer’s Disease Using Optical Coherence Tomography Angiography
Lahme, L., Esser, E. L., Mihailovic, N., Schubert, F., Lauermann, J. L., Johnen, A., Eter, N., Duning, T., & Alnawaiseh, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180738 · Cited by 126
Kulick, E. R., Elkind, M. S. V., Boehme, A. K., Joyce, N. R., Schupf, N., Kaufman, J. D., Mayeux, R. P., Manly, J. J., & Wellenius, G. A. (2020) · Environment International · doi:10.1016/j.envint.2019.105440 · Cited by 122
Mobile Apps for Caregivers of Older Adults: Quantitative Content Analysis
Grossman, M. R., Zak, D. K., & Zelinski, E. M. (2018) · JMIR mhealth and uhealth · doi:10.2196/mhealth.9345 · Cited by 128
Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease
Steeland, S., Gorlé, N., Vandendriessche, C., Balusu, S., Brkić, M., Cauwenberghe, C. V., Imschoot, G. V., Wonterghem, E. V., Rycke, R. M. D., Kremer, A., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708300 · Cited by 125
The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
Cárdenas-Aguayo, M. D. C., Gómez-Virgilio, L., DeRosa, S., & Meraz-Ríos, M. A. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500148z · Cited by 120
Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases
Salman, M. M., Al-Obaidi, Z. M. J., Kitchen, P., Loreto, A., Bill, R. M., & Wade‐Martins, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094688 · Cited by 121
“The estimated number of people aged 65 years or older in the USA with AD in 2010 was 4.7 million and this number is predicted to reach 13.8 million by 2050 [67].”
BackgroundInfluentialAkkol, E. K., Çankaya, İ. İ. T., Karatoprak, G. Ş., Çarpar, E., Sobarzo‐Sánchez, E., & Capasso, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.669638 · Cited by 128
“AD affects about 6–10% of people over 65 years (Burns and Iliffe, 2009; Hebert et al., 2013).”
BackgroundCellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.03.019 · Cited by 114
“By 2050, this number is projected to reach 16 million (Hebert et al., 2013).”
BackgroundMediterranean Diet in Preventing Neurodegenerative Diseases
Gardener, H., & Caunca, M. R. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0222-5 · Cited by 124
Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
Urrestarazu, E., & Iriarte, J. (2016) · Nature and Science of Sleep · doi:10.2147/nss.s76706 · Cited by 117
PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE
Hampel, H. J., O’Bryant, S. E., Castrillo, J. I., Ritchie, C. W., Rojkova, K., Broich, K., Benda, N., Nisticò, R., Frank, R., Dubois, B., et al. (2016) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2016.112 · Cited by 117
Projections of white and black older adults without living kin in the United States, 2015 to 2060
Verdery, A. M., & Margolis, R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710341114 · Cited by 117
Kabir, M. T., Uddin, M. S., Begum, M. M., Thangapandiyan, S., Rahman, M. S., Aleya, L., Mathew, B., Ahmed, M., Barreto, G. E., & Ashraf, G. M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191008103141 · Cited by 119
Kazim, S. F., & Iqbal, K. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0119-y · Cited by 126
The Role of microRNAs in Alzheimer’s Disease and Their Therapeutic Potentials
Shaik, M. M., Tamargo, I. A., Abubakar, M. B., Kamal, M. A., Greig, N. H., & Gan, S. H. (2018) · Genes · doi:10.3390/genes9040174 · Cited by 117
Zhang, R., Li, Y., Hu, B., Lu, Z., Zhang, J., & Zhang, X. (2016) · Advanced Materials · doi:10.1002/adma.201600554 · Cited by 116
Prusaczyk, B., Cherney, S. M., Carpenter, C. R., & DuBois, J. M. (2016) · Clinical Gerontologist · doi:10.1080/07317115.2016.1201714 · Cited by 115
Alzheimer's disease: The next frontier—Special Report 2017
Karlawish, J. H., Jack, C. R., Rocca, W. A., Snyder, H. M., & Carrillo, M. C. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.02.006 · Cited by 124
Kuller, L. H., López, O. L., Mackey, R. H., Rosano, C., Edmundowicz, D., Becker, J. T., & Newman, A. B. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.034 · Cited by 113
Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics
Blue, E., Horimoto, A. R. V. R., Mukherjee, S., Wijsman, E. M., & Thornton, T. A. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.07.016 · Cited by 113
Ríos, A. S., Oxenford, S., Neudorfer, C., Butenko, K., Li, N., Rajamani, N., Boutet, A., Elias, G. J. B., Germann, J., Loh, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34510-3 · Cited by 115
Korecka, M., Waligórska, T., Figurski, M., Toledo, J. B., Arnold, S. E., Grossman, M., Trojanowski, J. Q., & Shaw, L. M. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132489 · Cited by 117
Liu, Q., Radwanski, R. E., Babadjouni, R., Patel, A. B., Hodis, D. M., Baumbacher, P., Zhao, Z., Zloković, B. V., & Mack, W. J. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17743670 · Cited by 109
Lee, J., & Freeman, J. L. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.03.008 · Cited by 114
Kuo, P.-L., Huang, A., Ehrlich, J. R., Kasper, J. D., Lin, F. R., McKee, M. M., Reed, N. S., Swenor, B. K., & Deal, J. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1558 · Cited by 111
Jee, H. J., Lee, S. G., Bormate, K. J., & Jung, Y.-S. (2020) · Nutrients · doi:10.3390/nu12103080 · Cited by 111
“Even after accounting for differences in longevity, some studies have found that women are still at a higher risk [66].”
BackgroundNeurocognitive testing and cochlear implantation: insights into performance in older adults
Cosetti, M. K., Pinkston, J. B., Flores, J. M., Friedmann, D. R., Jones, C. M., Roland, J. T., & Waltzman, S. B. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s100255 · Cited by 110
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association
Lazar, R. M., Howard, V. J., Kernan, W. N., Aparicio, H. J., Levine, D. A., Viera, A. J., Jordan, L. C., Nyenhuis, D. L., Possin, K. L., Sorond, F. A., et al. (2021) · Stroke · doi:10.1161/str.0000000000000367 · Cited by 109
Handgrip Strength Is Associated with Poorer Cognitive Functioning in Aging Americans
McGrath, R., Robinson‐Lane, S. G., Cook, S. B., Clark, B. C., Herrmann, S. D., O’Connor, M. L., & Hackney, K. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190042 · Cited by 114
Purinergic receptors as potential therapeutic targets in Alzheimer's disease
Woods, L. T., Ajit, D., Camden, J. M., Erb, L., & Weisman, G. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.031 · Cited by 109
Matías‐Guiu, J. A., Valles‐Salgado, M., Rognoni, T., Hamre-Gil, F., Moreno‐Ramos, T., & Matías‐Guiu, J. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000469658 · Cited by 107
Amyloid Beta and MicroRNAs in Alzheimer’s Disease
Amakiri, N., Kubosumi, A., Tran, J., & Reddy, P. H. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00430 · Cited by 108
The Role of Mitochondrial Calcium Homeostasis in Alzheimer’s and Related Diseases
Ryan, K. C., Ashkavand, Z., & Norman, K. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239153 · Cited by 106
“In the United States alone, approximately 5 million people currently suffer from the disease, and these numbers are projected to triple by the year 2050 [2].”
BackgroundWang, H., Shang, Y., Wang, E., Xu, X., Zhang, Q., Qian, C., Yang, Z., Wu, S., & Zhang, T. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102280 · Cited by 107
Does Dementia Caregiving Accelerate Frailty? Findings From the Health and Retirement Study
Dassel, K. B., & Carr, D. C. (2016) · The Gerontologist · doi:10.1093/geront/gnu078 · Cited by 106
Ray, K. D., & Mittelman, M. S. (2015) · Dementia · doi:10.1177/1471301215613779 · Cited by 106
Yao, Y., Wang, K., & Xiang, H. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.154297 · Cited by 111
Remote Neuropsychological Assessment in Rural American Indians with and without Cognitive Impairment
Wadsworth, H. E., Galusha-Glasscock, J. M., Womack, K. B., Quiceno, M. E., Weiner, M., Hynan, L. S., Shore, J. H., & Cullum, C. M. (2016) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acw030 · Cited by 105
Zammit, A. R., Robitaille, A., Piccinin, A. M., Terrera, G. M., & Hofer, S. M. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly046 · Cited by 105
Yang, X., Diling, C., Yang, J. T., Ting, L., Guoyan, H., Hualun, L., Xiaocui, T., Lai, G., Shuai, O., Chaoqun, Z., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00412 · Cited by 110
Dementia Prevalence in Older Adults: Variation by Race/Ethnicity and Immigrant Status
Moon, H. E., Badana, A. N. S., Hwang, S.-Y., Sears, J. S., & Haley, W. E. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.11.003 · Cited by 106
Balbus, J. M., Crimmins, A. R., Gamble, J. L., Easterling, D. R., Kunkel, K. E., Saha, S., & Sarofim, M. C. (2016) · doi:10.7930/j0vx0dfw · Cited by 115
The Exceptional Vulnerability of Humans to Alzheimer’s Disease
Walker, L. C., & Jucker, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.04.001 · Cited by 108
Evaluation of Medicare Claims Data as a Tool to Identify Dementia
Lee, E., Gatz, M., Tseng, C.-C., Schneider, L. S., Pawluczyk, S., Wu, A. H., & Deapen, D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181005 · Cited by 104
Weuve, J., D’Souza, J. C., Beck, T. L., Evans, D. A., Kaufman, J. D., Rajan, K. B., de Leon, C. F. M., & Adar, S. D. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12191 · Cited by 109
Self-citationAPOE Genotype and Alzheimer’s Disease: The Influence of Lifestyle and Environmental Factors
Angelopoulou, E., Paudel, Y. N., Papageorgiou, S. G., & Piperi, C. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00295 · Cited by 109
Nutrient intake, nutritional status, and cognitive function with aging
Tucker, K. L. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13062 · Cited by 103
Interactions between inflammation, sex steroids, and Alzheimer’s disease risk factors
Uchoa, M. F., Moser, V. A., & Pike, C. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.09.001 · Cited by 105
Military Risk Factors for Cognitive Decline, Dementia and Alzheimer’s Disease
Veitch, D. P., Friedl, K. E., & Weiner, M. W. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990142 · Cited by 103
Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice
Ohia-Nwoko, O., Montazari, S., Lau, Y., & Eriksen, J. L. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-54 · Cited by 108
Levakov, G., Rosenthal, G., Shelef, I., Raviv, T. R., & Avidan, G. (2020) · Human Brain Mapping · doi:10.1002/hbm.25011 · Cited by 101
Christian, C. A., Reddy, D. S., Maguire, J., & Forcelli, P. A. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.017392 · Cited by 105
“Assessing sex differences in the relationship between epilepsy and Alzheimer disease, however, is somewhat complicated by differential incidence and progression of Alzheimer disease and other forms of aging-related dementia in women and men (Hebert et al., 2013; Pike, 2017; Ferretti et al., 2018).”
BackgroundTriggered palliative care for late-stage dementia: A pilot randomized trial
Hanson, L. C., Kistler, C. E., Lavin, K., Gabriel, S. L., Ernecoff, N. C., Lin, F.-C., Sachs, G. A., & Mitchell, S. L. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.10.494 · Cited by 92
The Proteasome and Oxidative Stress in Alzheimer's Disease
Bonet-Costa, V., Pomatto, L. C.-D., & Davies, K. J. A. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6802 · Cited by 99
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
Schindler, S. E., Li, Y., Todd, K. W., Herries, E. M., Henson, R. L., Gray, J. D., Wang, G., Graham, D. L., Shaw, L. M., Trojanowski, J. Q., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.12.019 · Cited by 101
Hunt, L. J., Covinsky, K. E., Yaffe, K. S., Stephens, C. E., Miao, Y., Boscardin, W. J., & Smith, A. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13536 · Cited by 101
Liao, X., Li, G., Wang, A., Liu, T., Feng, S., Guo, Z., Tang, Q., Jin, Y., Xing, G., McClure, M. A., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150346 · Cited by 100
Leonpacher, A. K., Peters, M. E., Drye, L. T., Makino, K. M., Newell, J. A., Devanand, D. P., Frangakis, C., Munro, C. A., Mintzer, J. E., Pollock, B. G., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15020248 · Cited by 104
Vinceti, M., Chiari, A., Eichmüller, M., Rothman, K. J., Filippini, T., Malagoli, C., Weuve, J., Tondelli, M., Zamboni, G., Nichelli, P., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0323-1 · Cited by 112
Self-citationRelative risk for Alzheimer disease based on complete family history
Cannon‐Albright, L., Foster, N. L., Schliep, K. C., Farnham, J. M., Teerlink, C. C., Kaddas, H. K., Tschanz, J. T., Corcoran, C., & Kauwe, J. S. K. (2019) · Neurology · doi:10.1212/wnl.0000000000007231 · Cited by 116
Yang, D., Huang, R., Yoo, S.-H., Shin, M., Yoon, J. A., Shin, Y., & Hong, K. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00141 · Cited by 98
Advances in Alzheimer’s disease’s pharmacological treatment
Filho, C. E. C., Loss, L. B., Pereira, C. M., Rossoni, J. V., Barcelos, R. M., Chiarelli-Neto, O., da Silva, B. S., Ambrósio, R. P., Castro, F. C. D. A. Q., Teixeira, S. F., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1101452 · Cited by 107
Privacy Preservation in Big Data From the Communication Perspective—A Survey
Wang, T., Zheng, Z., Rehmani, M. H., Yao, S., & Huo, Z. (2018) · IEEE Communications Surveys & Tutorials · doi:10.1109/comst.2018.2865107 · Cited by 99
The Self-Care Needs and Behaviors of Dementia Informal Caregivers: A Systematic Review
Waligora, K. J., Bahouth, M. N., & Han, H.-R. (2019) · The Gerontologist · doi:10.1093/geront/gny076 · Cited by 98
Liu, J., Hlavka, J., Hillestad, R., & Mattke, S. (2017) · doi:10.7249/rr2272 · Cited by 98
Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings
Henley, D. B., Sundell, K. L., Sethuraman, G., Dowsett, S. A., & May, P. C. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.939167 · Cited by 98
p53 in neurodegenerative diseases and brain cancers
Checler, F., & da Costa, C. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.009 · Cited by 99
Kim, M. G., Nevado‐Holgado, A. J., Whiley, L., Snowden, S. G., Soininen, H. S., Kłoszewska, I., Mecocci, P., Tsolaki, M., Vellas, B. J., Thambisetty, M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160645 · Cited by 98
Jones, E. A. A., Gillespie, A. K., Yoon, S. Y., Frank, L. M., & Huang, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.056 · Cited by 103
Impact of multisession 40Hz tACS on hippocampal perfusion in patients with Alzheimer’s disease
Sprugnoli, G., Munsch, F., Cappon, D., Paciorek, R., Macone, J., Connor, A., El Fakhri, G., Salvador, R., Ruffini, G., Donohoe, K., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00922-4 · Cited by 99
“Background Alzheimer’s disease (AD) is the most common cause of dementia, and its prevalence continues to increase [1].”
BackgroundGenetic variants in Alzheimer disease — molecular and brain network approaches
Gaiteri, C., Mostafavi, S., Honey, C. J., Jager, P. L. D., & Bennett, D. A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.84 · Cited by 97
Automatic dementia screening and scoring by applying deep learning on clock-drawing tests
Chen, S., Stromer, D., Alabdalrahim, H. A., Schwab, S., Weih, M., & Maier, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-74710-9 · Cited by 99
“(2) The test takes usually place at the clinic.”
BackgroundMethodNeuner, S. M., Wilmott, L. A., Hoffmann, B. R., Mozhui, K., & Kaczorowski, C. C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.06.002 · Cited by 95
Peng, Q., Bakulski, K. M., Nan, B., & Park, S. K. (2017) · Environmental Research · doi:10.1016/j.envres.2017.05.011 · Cited by 95
Lupus nephritis. Classification, prognosis, immunopathogenesis, and treatment.
Golbus, J., & McCune, W. J. (1994) · PubMed · Cited by 96
Healthy Aging Brain Center Improved Care Coordination And Produced Net Savings
French, D. D., LaMantia, M. A., Livin, L. R., Herceg, D., Alder, C. A., & Boustani, M. A. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1221 · Cited by 93
Popuri, K., Ma, D., Wang, L., & Beg, M. F. (2020) · Human Brain Mapping · doi:10.1002/hbm.25115 · Cited by 96
Asadi, F., Jamshidi, A. H., Khodagholi, F., Yans, A., Azimi, L., Faizi, M., Vali, L., Abdollahi, M. R., Ghahremani, M. H., & Sharifzadeh, M. S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.10.011 · Cited by 95
Metadata
- Authors
- Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A.
- Affiliations
- Rush University (US)
- Venue
- Neurology
- Published
- 2013-05-07
- Volume
- 80
- Issue
- 19
- Pages
- 1778-1783
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3719424
- OpenAlex
- W2071068165
- Cited by
- 2,642
- References
- 19
- Citations by year
- 2026: 81 · 2025: 119 · 2024: 192 · 2023: 167 · 2022: 242 · 2021: 312 · 2020: 317 · 2019: 232 · 2018: 210 · 2017: 212 · 2016: 217 · 2015: 160 · 2014: 129 · 2013: 47
- FWCI
- 131.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (AG011101)
- National Institute on Aging (RC2AG036650, U01AG012505, R01AG030146, AG011101, R01AG011101, P30AG010161, R01AG021972, R01AG009966)
- National Heart, Lung, and Blood Institute (R01HL084209)
- National Institute of Nursing Research (R01NR009543, R01NR010211)
- National Institute of Environmental Health Sciences (R21ES020404, R01ES010902, R21ES019712)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Social Sciences › Demography › Insurance, Mortality, Demography, Risk Management
- Keywords
- Alzheimer's disease, dementia prevalence, population projections, older adults, age-specific prevalence, racial differences, educational attainment, population aging, United States
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Forecasting, Humans, Longitudinal Studies, Male, Population Surveillance, United States, Incidence, Censuses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
